1052 related articles for article (PubMed ID: 30012085)
1. Association between nonalcoholic fatty liver disease and subclinical atherosclerosis: a cross-sectional study on population over 40 years old.
Zheng J; Zhou Y; Zhang K; Qi Y; An S; Wang S; Zhao X; Tang YD
BMC Cardiovasc Disord; 2018 Jul; 18(1):147. PubMed ID: 30012085
[TBL] [Abstract][Full Text] [Related]
2. Advanced fibrosis associates with atherosclerosis in subjects with nonalcoholic fatty liver disease.
Chen Y; Xu M; Wang T; Sun J; Sun W; Xu B; Huang X; Xu Y; Lu J; Li X; Wang W; Bi Y; Ning G
Atherosclerosis; 2015 Jul; 241(1):145-50. PubMed ID: 25988358
[TBL] [Abstract][Full Text] [Related]
3. Nonalcoholic fatty liver disease is an independent risk factor for atherosclerosis in young adult men.
Ozturk K; Uygun A; Guler AK; Demirci H; Ozdemir C; Cakir M; Sakin YS; Turker T; Sari S; Demirbas S; Karslıoğlu Y; Saglam M
Atherosclerosis; 2015 Jun; 240(2):380-6. PubMed ID: 25875390
[TBL] [Abstract][Full Text] [Related]
4. Associations of subclinical atherosclerosis with nonalcoholic fatty liver disease and fibrosis assessed by non-invasive score.
Xin Z; Zhu Y; Wang S; Liu S; Xu M; Wang T; Lu J; Chen Y; Zhao Z; Wang W; Ning G; Bi Y; Xu Y; Li M
Liver Int; 2020 Apr; 40(4):806-814. PubMed ID: 31820847
[TBL] [Abstract][Full Text] [Related]
5. Nonalcoholic fatty liver disease is associated with atherosclerosis in middle-aged and elderly Chinese.
Huang Y; Bi Y; Xu M; Ma Z; Xu Y; Wang T; Li M; Liu Y; Lu J; Chen Y; Huang F; Xu B; Zhang J; Wang W; Li X; Ning G
Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2321-6. PubMed ID: 22814750
[TBL] [Abstract][Full Text] [Related]
6. Autonomic dysfunction assessed by EZSCAN and subclinical atherosclerosis.
Sun J; Zhang Y; Xu B; Lv X; Ding L; Chen Y; Sun W; Lu J; Xu M; Bi Y; Ning G
J Diabetes; 2014 Sep; 6(5):409-16. PubMed ID: 24506497
[TBL] [Abstract][Full Text] [Related]
7. Subclinical atherosclerosis and arterial stiffness in nonalcoholic fatty liver disease: A case-control study in Algerian population.
Taharboucht S; Guermaz R; Brouri M; Chibane A
J Med Vasc; 2021 May; 46(3):129-138. PubMed ID: 33990287
[TBL] [Abstract][Full Text] [Related]
8. Association of Fetuin-B with Subclinical Atherosclerosis in Obese Chinese Adults.
Li Z; He C; Liu Y; Wang D; Lin M; Liu C; Shi X; Chen Z; Li X; Yang S; Li W
J Atheroscler Thromb; 2020 May; 27(5):418-428. PubMed ID: 31527322
[TBL] [Abstract][Full Text] [Related]
9. The progression and regression of metabolic dysfunction-associated fatty liver disease are associated with the development of subclinical atherosclerosis: A prospective analysis.
Liu S; Wang J; Wu S; Niu J; Zheng R; Bie L; Xin Z; Wang S; Lin H; Zhao Z; Wang T; Xu M; Lu J; Chen Y; Xu Y; Wang W; Ning G; Bi Y; Li M; Xu Y
Metabolism; 2021 Jul; 120():154779. PubMed ID: 33895182
[TBL] [Abstract][Full Text] [Related]
10. Nonalcoholic Fatty Liver Disease Is Associated With Arterial Distensibility and Carotid Intima-Media Thickness: (from the Multi-Ethnic Study of Atherosclerosis).
Oni E; Budoff MJ; Zeb I; Li D; Veledar E; Polak JF; Blankstein R; Wong ND; Blaha MJ; Agatston A; Blumenthal RS; Nasir K
Am J Cardiol; 2019 Aug; 124(4):534-538. PubMed ID: 31262497
[TBL] [Abstract][Full Text] [Related]
11. Frequency of Nonalcoholic Fatty Liver Disease and Subclinical Atherosclerosis Among Young Mexican Americans.
Gill C; Vatcheva KP; Pan JJ; Smulevitz B; McPherson DD; Fallon M; McCormick JB; Fisher-Hoch SP; Laing ST
Am J Cardiol; 2017 Jun; 119(11):1717-1722. PubMed ID: 28395890
[TBL] [Abstract][Full Text] [Related]
12. The association of fatty pancreas with subclinical atherosclerosis in nonalcoholic fatty liver disease.
Ozturk K; Dogan T; Celikkanat S; Ozen A; Demirci H; Kurt O; Turker T; Yilmaz Y; Uygun A
Eur J Gastroenterol Hepatol; 2018 Apr; 30(4):411-417. PubMed ID: 29309395
[TBL] [Abstract][Full Text] [Related]
13. Correlations of non-alcoholic fatty liver disease and serum uric acid with subclinical atherosclerosis in obese Chinese adults.
Liu Y; Liu C; Shi X; Lin M; Yan B; Zeng X; Chen N; Lu S; Liu S; Yang S; Li X; Li Z
J Diabetes; 2017 Jun; 9(6):586-595. PubMed ID: 27371101
[TBL] [Abstract][Full Text] [Related]
14. The synergistic impact of nonalcoholic fatty liver disease and metabolic syndrome on subclinical atherosclerosis.
Hong HC; Hwang SY; Ryu JY; Yoo HJ; Seo JA; Kim SG; Kim NH; Baik SH; Choi DS; Choi KM
Clin Endocrinol (Oxf); 2016 Feb; 84(2):203-209. PubMed ID: 26342196
[TBL] [Abstract][Full Text] [Related]
15. Comparison of anthropometric measurements for prediction of the atherosclerosis and liver histology in young adults with nonalcoholic fatty liver disease.
Dogan T; Ozturk K; Celikkanat S; Aykan MB; Uygun A
Eur J Gastroenterol Hepatol; 2019 Nov; 31(11):1460-1466. PubMed ID: 31045630
[TBL] [Abstract][Full Text] [Related]
16. Carotid stiffness and atherosclerotic risk: non-invasive quantification with ultrafast ultrasound pulse wave velocity.
Zhu ZQ; Chen LS; Wang H; Liu FM; Luan Y; Wu LL; Liu N; Wang P; Huang H
Eur Radiol; 2019 Mar; 29(3):1507-1517. PubMed ID: 30187117
[TBL] [Abstract][Full Text] [Related]
17. Nonalcoholic fatty liver disease is associated with subclinical atherosclerosis independent of obesity and metabolic syndrome in Asian Indians.
Thakur ML; Sharma S; Kumar A; Bhatt SP; Luthra K; Guleria R; Pandey RM; Vikram NK
Atherosclerosis; 2012 Aug; 223(2):507-11. PubMed ID: 22748277
[TBL] [Abstract][Full Text] [Related]
18. Association of Nonalcoholic Fatty Liver Disease With Lower Brain Volume in Healthy Middle-aged Adults in the Framingham Study.
Weinstein G; Zelber-Sagi S; Preis SR; Beiser AS; DeCarli C; Speliotes EK; Satizabal CL; Vasan RS; Seshadri S
JAMA Neurol; 2018 Jan; 75(1):97-104. PubMed ID: 29159396
[TBL] [Abstract][Full Text] [Related]
19. The TyG Index as a Marker of Subclinical Atherosclerosis and Arterial Stiffness in Lean and Overweight Postmenopausal Women.
Lambrinoudaki I; Kazani MV; Armeni E; Georgiopoulos G; Tampakis K; Rizos D; Augoulea A; Kaparos G; Alexandrou A; Stamatelopoulos K
Heart Lung Circ; 2018 Jun; 27(6):716-724. PubMed ID: 28690023
[TBL] [Abstract][Full Text] [Related]
20. A significant risk of metabolic dysfunction-associated fatty liver disease plus diabetes on subclinical atherosclerosis.
Bessho R; Kashiwagi K; Ikura A; Yamataka K; Inaishi J; Takaishi H; Kanai T
PLoS One; 2022; 17(5):e0269265. PubMed ID: 35639744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]